PrognostIc and Predictive Factors in Unresectable Locally Advanced NEC and MANEC

100 participants · First posted May 6, 2024

Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.

78 participants · First posted Jun 3, 2024

Avelumab in G3 NEC

10 participants · First posted Sep 11, 2017

hepatocellular carcinoma program

Hepatocellular carcinoma(Engitix)

renal cell carcinoma program

Crinetics

United States

Senti Biosciences, Inc.

United States

ABD-147 and PT217 Receive FDA Orphan Drug Designations for Neuroendocrine Carcinoma Treatment

LBL-024 Bispecific Antibody Shows 75% Response Rate in Advanced Neuroendocrine Carcinoma Trial

Leads Biolabs' LBL-024 Receives FDA Orphan Drug Designation for Neuroendocrine Cancer